analyst
AC
NASDAQ · ACIU
AC Immune S.A.
Healthcare · Biotechnology
$2.69
Down-$0.07 (-2.54%)
Updated Sep 11, 2026, 3:51 AM
SID Score
5.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 294.76M
- P/E ratio
- -3.11
- Dividend yield
- 0.00%
- 52-week range
- $2.10 – $3.49
- Volume
- 157.53K
- Avg. volume
- 714.24K
Price performance
ACIU price history
1M range · 20 trading sessions · Daily adjusted prices
ACIU closed at $2.69 after 20 trading sessions, up 4.67% for the selected period.
- Last close
- $2.69
- Period change
- +4.67%
- Period low
- $2.49
- Period high
- $2.93
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | $2.74 | $2.77 | $2.68 | $2.69 | 157.53K |
| Sep 9, 2026 | $2.78 | $2.81 | $2.725 | $2.76 | 146.57K |
| Sep 8, 2026 | $2.82 | $2.85 | $2.77 | $2.78 | 100.87K |
| Sep 4, 2026 | $2.91 | $2.94 | $2.82 | $2.86 | 155.63K |
| Sep 3, 2026 | $2.85 | $3.00 | $2.85 | $2.93 | 171.77K |
| Sep 2, 2026 | $2.70 | $2.865 | $2.70 | $2.84 | 257.18K |
| Sep 1, 2026 | $2.62 | $2.68 | $2.58 | $2.68 | 103.47K |
| Aug 31, 2026 | $2.67 | $2.735 | $2.61 | $2.64 | 132.96K |
| Aug 28, 2026 | $2.73 | $2.77 | $2.65 | $2.65 | 105.71K |
| Aug 27, 2026 | $2.83 | $2.91 | $2.685 | $2.71 | 169.43K |
| Aug 26, 2026 | $2.94 | $2.98 | $2.77 | $2.85 | 269.06K |
| Aug 25, 2026 | $2.85 | $2.965 | $2.85 | $2.92 | 241.3K |
| Aug 24, 2026 | $2.91 | $3.00 | $2.7986 | $2.86 | 371.17K |
| Aug 21, 2026 | $2.66 | $2.945 | $2.65 | $2.90 | 442.01K |
| Aug 20, 2026 | $2.60 | $2.65 | $2.435 | $2.64 | 237.11K |
| Aug 19, 2026 | $2.60 | $2.69 | $2.565 | $2.58 | 280.71K |
| Aug 18, 2026 | $2.54 | $2.59 | $2.505 | $2.57 | 90.23K |
| Aug 17, 2026 | $2.49 | $2.565 | $2.4698 | $2.53 | 104.65K |
| Aug 14, 2026 | $2.58 | $2.58 | $2.4301 | $2.49 | 133.24K |
| Aug 13, 2026 | $2.59 | $2.645 | $2.55 | $2.57 | 217.31K |
Latest ACIU news
The latest Smart Investors Daily articles mentioning ACIU.
Stock researchMarket Activity · Insider Trades
Loading stock research…

